Department of Laboratory Medicine, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
Scientific Research, Scientific Affairs, Sysmex Corporation, Kobe, Japan.
Int J Hematol. 2022 Feb;115(2):173-187. doi: 10.1007/s12185-021-03256-x. Epub 2021 Nov 9.
Patients with non-severe hemophilia A often show discrepancies in factor VIII (FVIII) activity. However, information on variant-specific coagulation assay characteristics in Japanese patients is limited. Pathogenic variants were classified into three groups, thrombin-cleavage site (TC), A1-A2-A3 interface (IF), and non-discrepant, with reference to previous studies. Cutoff values for the one-stage assay (OSA)/chromogenic substrate assay (CSA) ratio, which is suitable for distinguishing discrepancies, were determined for all five aPTT reagents. TGA and CWA parameters and bleeding scores were compared between groups. Two of the 39 patients with non-severe hemophilia A (5%) were classified as TC, 10 (26%) as IF, and 27 (69%) as non-discrepant. The OSA/CSA cutoff values between the groups varied widely by aPTT reagent and tended to be relatively low compared to previous studies. As an indicator of bleeding tendency, TGA had a low correlation coefficient for the IF variant, but this was not significant and was comparable to FVIII activity and CWA. Moreover, various parameters and bleeding tendency differed among patients with the same variants. Thus, our findings suggest that it is difficult to adequately assess the bleeding tendency of individual patients, even with the various assessments currently available.
非重型血友病 A 患者的因子 VIII (FVIII) 活性常存在差异。然而,关于日本患者变异特异性凝血检测特征的信息有限。根据以往的研究,将致病性变异分为三个组:凝血酶裂解位点 (TC)、A1-A2-A3 界面 (IF) 和无差异。为所有五种活化部分凝血活酶时间 (aPTT) 试剂确定了适合区分差异的一期法 (OSA)/发色底物法 (CSA) 比值的截断值。比较了各组之间的 TGA 和 CWA 参数和出血评分。39 名非重型血友病 A 患者中有 2 名 (5%) 被归类为 TC,10 名 (26%) 为 IF,27 名 (69%) 为无差异。各组之间的 OSA/CSA 截断值因 aPTT 试剂而异,与以往的研究相比,这些截断值往往相对较低。作为出血倾向的指标,IF 变异的 TGA 相关系数较低,但无统计学意义,与 FVIII 活性和 CWA 相当。此外,具有相同变异的患者的各种参数和出血倾向存在差异。因此,我们的研究结果表明,即使目前有各种评估方法,也很难充分评估个体患者的出血倾向。